Skip to content

Topic - Bevacizumab

Bevacizumab is currently approved by the U.S. Food and Drug Administration (FDA) for cancers that are metastatic (have spread to other parts of the body). It received its first approval in 2004 for combination use with standard chemotherapy for metastatic colon cancer and non-small cell lung cancer. who objected because it only slowed tumor growth but failed to extend survival. In the US, Members of a Food and Drug Administration panel said in July 2010 that they do not see enough of a benefit from Avastin in advanced breast cancer to justify its serious risks, although the drug is still approved for use in Australia. - Source: Wikipedia

Related Stories